These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2170524)

  • 1. Phenotypic and functional characteristics of in vivo-activated Langerhans cells.
    Aiba S; Katz SI
    J Immunol; 1990 Nov; 145(9):2791-6. PubMed ID: 2170524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short-term culture.
    Girolomoni G; Simon JC; Bergstresser PR; Cruz PD
    J Immunol; 1990 Nov; 145(9):2820-6. PubMed ID: 2212664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
    Dai R; Grammer SF; Streilein JW
    J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
    J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen.
    Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI
    J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
    Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
    Shimizu T; Abe R; Nishihira J; Shibaki A; Watanabe H; Nakayama T; Taniguchi M; Ishibashi T; Shimizu H
    Eur J Immunol; 2003 Jun; 33(6):1478-87. PubMed ID: 12778465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin.
    Enk AH; Angeloni VL; Udey MC; Katz SI
    J Immunol; 1993 May; 150(9):3698-704. PubMed ID: 8473727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
    Steiner G; Wolff K; Pehamberger H; Stingl G
    J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11bbright monocytic/macrophagic cells.
    Hammerberg C; Duraiswamy N; Cooper KD
    J Immunol; 1994 Dec; 153(11):4915-24. PubMed ID: 7963554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function.
    Péguet-Navarro J; Dalbiez-Gauthier C; Dezutter-Dambuyant C; Schmitt D
    Eur J Immunol; 1993 Feb; 23(2):376-82. PubMed ID: 8436173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of epitopes recognized by hapten-specific CD4+ T cells.
    Cavani A; Hackett CJ; Wilson KJ; Rothbard JB; Katz SI
    J Immunol; 1995 Feb; 154(3):1232-8. PubMed ID: 7529797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturational steps of bone marrow-derived dendritic murine epidermal cells. Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period.
    Elbe A; Tschachler E; Steiner G; Binder A; Wolff K; Stingl G
    J Immunol; 1989 Oct; 143(8):2431-8. PubMed ID: 2571637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
    Enk AH; Angeloni VL; Udey MC; Katz SI
    J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation.
    Kobayashi Y; Matsumoto M; Kotani M; Makino T
    J Immunol; 1999 Dec; 163(11):5989-93. PubMed ID: 10570286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.
    Streilein JW; Grammer SF
    J Immunol; 1989 Dec; 143(12):3925-33. PubMed ID: 2592763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
    Atarashi K; Kabashima K; Akiyama K; Tokura Y
    Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.